Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q3
Sell
-6,095
Closed -$209K 106
2018
Q2
$209K Buy
+6,095
New +$208K 0.36% 103
2018
Q1
Sell
-28,107
Closed -$965K 112
2017
Q4
$965K Buy
28,107
+1,450
+5% +$49.4K 1.6% 13
2017
Q3
$903K Sell
26,657
-2,177
-8% -$70K 1.57% 13
2017
Q2
$919K Sell
28,834
-2,668
-8% -$84.1K 1.7% 10
2017
Q1
$1.02M Sell
31,502
-457
-1% -$14.4K 1.86% 9
2016
Q4
$984K Buy
31,959
+4,885
+18% +$149K 1.86% 7
2016
Q3
$870K Buy
27,074
+17,013
+169% +$569K 1.71% 12
2016
Q2
$300K Sell
10,061
-1,817
-15% -$58K 0.56% 79
2016
Q1
$334K Buy
11,878
+2,965
+33% +$84.7K 0.58% 73
2015
Q4
$273K Sell
8,913
-1,148
-11% -$36.1K 0.49% 88
2015
Q3
$300K Sell
10,061
-1,302
-11% -$41.7K 0.55% 82
2015
Q2
$362K Sell
11,363
-177
-2% -$5.77K 0.49% 81
2015
Q1
$381K Sell
11,540
-3,184
-22% -$101K 0.54% 73
2014
Q4
$435K Sell
14,724
-464
-3% -$13.3K 0.47% 79
2014
Q3
$427K Sell
15,188
-167
-1% -$4.69K 0.49% 78
2014
Q2
$432K Sell
15,355
-38,958
-72% -$1.11M 0.52% 76
2014
Q1
$1.66M Buy
54,313
+8,633
+19% +$257K 1.72% 2
2013
Q4
$1.33M Sell
45,680
-4,692
-9% -$137K 1.34% 10
2013
Q3
$1.37M Sell
50,372
-3,839
-7% -$104K 1.38% 7
2013
Q2
$1.44M Buy
+54,211
New +$1.5M 1.48% 7

Other funds holding PFE

Banced Corp's PFE Position: Q3 2018 in Review

Banced Corp sold out of Pfizer (PFE) in Q3 2018, closing a stake of 6,095 shares — an estimated $209K sold.

Banced Corp first reported a position in PFE in Q2 2013 and held it in 20 quarters. The position peaked at $1.66M in Q1 2014. 2,256 funds tracked by Wall St. Rank hold PFE as of Q3 2018.

  • Banced Corp reported no remaining Pfizer position as of Q3 2018 after selling out during the quarter.
  • Banced Corp sold 6,095 Pfizer shares in Q3 2018, an estimated $209K.
  • Banced Corp first reported a position in Pfizer in Q2 2013 and held it in 20 quarters.
  • Banced Corp's Pfizer position peaked at $1.66M in Q1 2014.
  • 2,256 funds tracked by Wall St. Rank held Pfizer as of Q3 2018.

Based on Banced Corp's 13F filing for Q3 2018, filed 10 Oct 2018.